U-DESPE: a Bayesian Utility-based methodology for dosing regimen optimization in early-phase oncology trials based on Dose-Exposure, Safety, Pharmacodynamics, Efficacy
Fuente:
arXiv
Saved in:
| Main Authors: | Andrillon, Anaïs, Micallef, Sandrine, Ursino, Moreno, Mozgunov, Pavel, Riviere, Marie-Karelle |
|---|---|
| Format: | Preprint |
| Published: |
2025
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Sample size reassessment in Bayesian hybrid clinical trials
by: Ratta, Marco, et al.
Published: (2025)
by: Ratta, Marco, et al.
Published: (2025)
Using joint models in phase I dose-finding designs in oncology: considerations for frequentist approaches
by: Chen, Xijin, et al.
Published: (2025)
by: Chen, Xijin, et al.
Published: (2025)
On Inclusion of Covariates in Model Based Dose Finding Clinical Trial Designs
by: Adrien Ollier, et al.
Published: (2025)
by: Adrien Ollier, et al.
Published: (2025)
Robust Bayesian hierarchical models for basket trials enabling joint evaluation of toxicity and efficacy
by: Cao, Zhi, et al.
Published: (2025)
by: Cao, Zhi, et al.
Published: (2025)
Evaluating hybrid controls methodology in early-phase oncology trials: a simulation study based on the MORPHEUS-UC trial
by: Wang, Guanbo, et al.
Published: (2022)
by: Wang, Guanbo, et al.
Published: (2022)
Design specification of Partial Ordering Continual Reassessment Method based on consistency conditions
by: Chen, Weishi, et al.
Published: (2024)
by: Chen, Weishi, et al.
Published: (2024)
A response-adaptive multi-arm design for continuous endpoints based on a weighted information measure
by: Caruso, Gianmarco, et al.
Published: (2024)
by: Caruso, Gianmarco, et al.
Published: (2024)
Partial Ordering Bayesian Logistic Regression Model for Phase I Combination Trials and Computationally Efficient Approach to Operational Prior Specification
by: Chen, Weishi, et al.
Published: (2024)
by: Chen, Weishi, et al.
Published: (2024)
Meta‐analyses of phase I dose‐finding studies: Application for the development of protein kinase inhibitors in oncology
by: Laura Caquelin, et al.
Published: (2024)
by: Laura Caquelin, et al.
Published: (2024)
A multi-arm multi-stage design for trials with all pairwise testing
by: Greenstreet, Peter, et al.
Published: (2025)
by: Greenstreet, Peter, et al.
Published: (2025)
Bayesian Model Averaging for Partial Ordering Continual Reassessment Methods
by: Kovacevic, Luka, et al.
Published: (2024)
by: Kovacevic, Luka, et al.
Published: (2024)
Adaptive Biomarker‐Based Design for Early Phase Clinical Trials
by: Alessandra Serra, et al.
Published: (2025)
by: Alessandra Serra, et al.
Published: (2025)
Caring for caregivers in early‐phase clinical oncology trials
by: Leah L. Thompson, et al.
Published: (2025)
by: Leah L. Thompson, et al.
Published: (2025)
Safety, Pharmacokinetics, and Pharmacodynamics of Etrasimod: Single and Multiple Ascending Dose Studies in Healthy Adults
by: Caroline A. Lee, et al.
Published: (2024)
by: Caroline A. Lee, et al.
Published: (2024)
Land Back: Indigenous sovereignty as care through responsibility and relationship
by: Karelle Hall
Published: (2024)
by: Karelle Hall
Published: (2024)
On the turtle's back: Stories the Lenape told their grandchildren By CamillaTownsend and Nicky KayMichael. New Brunswick, NJ: Rutgers University Press, 2023. 250 pp.
by: Karelle Hall
Published: (2025)
by: Karelle Hall
Published: (2025)
On the interplay between prior weight and variance of the robustification component in Robust Mixture Prior Bayesian Dynamic Borrowing approach
by: Ratta, Marco, et al.
Published: (2025)
by: Ratta, Marco, et al.
Published: (2025)
On the Interplay Between Prior Weight and Variance of the Robustification Component in Robust Mixture Prior Bayesian Dynamic Borrowing Approach
by: Marco Ratta, et al.
Published: (2026)
by: Marco Ratta, et al.
Published: (2026)
Effect of Cumulative Exposure on the Efficacy of Paroxetine: A Population Pharmacokinetic‐Pharmacodynamic and Machine Learning Analyses
by: Keiichi Shigetome, et al.
Published: (2025)
by: Keiichi Shigetome, et al.
Published: (2025)
Straightforward Phase I Dose-Finding Design for Healthy Volunteers Accounting for Surrogate Activity Biomarkers
by: Boulet, Sandrine, et al.
Published: (2024)
by: Boulet, Sandrine, et al.
Published: (2024)
Next generation clinical trials: Seamless designs and master protocols
by: Burdon, Abigail, et al.
Published: (2024)
by: Burdon, Abigail, et al.
Published: (2024)
Translational Pharmacokinetic‐Pharmacodynamic Modeling and Efficacious Human Dose Prediction of DNDI ‐6148 for the Treatment of Cutaneous Leishmaniasis
by: Rasmus Hansen Henninger, et al.
Published: (2026)
by: Rasmus Hansen Henninger, et al.
Published: (2026)
On the relative conservativeness of Bayesian logistic regression method in oncology dose‐finding studies
by: Cheng‐Han Yang, et al.
Published: (2024)
by: Cheng‐Han Yang, et al.
Published: (2024)
Bayesian Framework for Multi-Source Data Integration -- Application to Human Extrapolation From Preclinical Studies
by: Boulet, Sandrine, et al.
Published: (2022)
by: Boulet, Sandrine, et al.
Published: (2022)
Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous and Intravenous Garadacimab Following Single‐Dose Administration in Healthy Japanese and White Adults
by: Fiona Glassman, et al.
Published: (2024)
by: Fiona Glassman, et al.
Published: (2024)
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses and Dose Titration of Bexicaserin in Healthy Participants in a Randomized, Double‐Blind, Placebo‐Controlled Study
by: Jonathan Williams, et al.
Published: (2025)
by: Jonathan Williams, et al.
Published: (2025)
A Utility Score Framework for Dose Optimization Studies with Binary Efficacy-Safety Endpoints: Sample Size Determination and Bias Characterization
by: Gu, Xuemin, et al.
Published: (2026)
by: Gu, Xuemin, et al.
Published: (2026)
A Phase I/IB, Open Label, Dose Finding Study to Evaluate Safety, Pharmacodynamics and Efficacy of Pembrolizumab in Combination With Vorinostat in Patients With Advanced Prostate, Renal or Urothelial Carcinoma
by: Roberto Pili, et al.
Published: (2025)
by: Roberto Pili, et al.
Published: (2025)
Comment on: Incorporation of patient‐reported outcomes in early‐phase clinical trials for childhood and adolescent cancer
by: Gabriel Revon‐Riviere, et al.
Published: (2024)
by: Gabriel Revon‐Riviere, et al.
Published: (2024)
Population Pharmacokinetics, Pharmacodynamics and Safety Properties of Trametinib in Dogs With Cancer: A Phase I Dose Escalating Clinical Trial
by: Marilia Takada, et al.
Published: (2024)
by: Marilia Takada, et al.
Published: (2024)
Utility-based optimization of Fujikawa's basket trial design -- Pre-specified protocol of a comparison study
by: Sauer, Lukas D, et al.
Published: (2024)
by: Sauer, Lukas D, et al.
Published: (2024)
APORTES DE LA PSICOLOGÍA DEL DEPORTE PARA CONCEPTUALIZAR, OPERACIONALIZAR Y MAXIMIZAR EL RENDIMIENTO DEPORTIVO
by: Damián J. Ursino
Published: (2018)
by: Damián J. Ursino
Published: (2018)
LA EVALUACIÓN DEL RENDIMIENTO DEPORTIVO EN PSICOLOGÍA DEL DEPORTE: UNA REVISIÓN SISTEMÁTICA
by: Damián J. Ursino
Published: (2019)
by: Damián J. Ursino
Published: (2019)
Utility of recruitment incentives in early Alzheimer’s disease clinical trials
by: Marina Ritchie, et al.
Published: (2024)
by: Marina Ritchie, et al.
Published: (2024)
A Randomized, Parallel, Open‐Label, Single‐Dose and Multiple‐Dose Clinical Trial to Investigate the Pharmacokinetic, Pharmacodynamic, and Safety Profiles of Obicetrapib in Healthy Participants in China
by: Jing Zhang, et al.
Published: (2024)
by: Jing Zhang, et al.
Published: (2024)
Latent Neural-ODE for Model-Informed Precision Dosing: Overcoming Structural Assumptions in Pharmacokinetics
by: Maurel, Benjamin, et al.
Published: (2026)
by: Maurel, Benjamin, et al.
Published: (2026)
Realizing the promise of Project Optimus: Challenges and emerging opportunities for dose optimization in oncology drug development
by: Wei Gao, et al.
Published: (2024)
by: Wei Gao, et al.
Published: (2024)
A Preplanned Multi‐Stage Platform Trial for Discovering Multiple Superior Treatments With Control of FWER and Power
by: Peter Greenstreet, et al.
Published: (2024)
by: Peter Greenstreet, et al.
Published: (2024)
An information metric for comparing and assessing informative interim decisions in sequential clinical trials
by: Caruso, G., et al.
Published: (2025)
by: Caruso, G., et al.
Published: (2025)
Pharmacokinetics, Pharmacodynamics, Efficacy and Drug Resistance Selection of Injectable Long‐Acting Lenacapavir Pre‐Exposure Prophylaxis ( PrEP ) Against HIV
by: Hee‐yeong Kim, et al.
Published: (2026)
by: Hee‐yeong Kim, et al.
Published: (2026)
Similar Items
-
Sample size reassessment in Bayesian hybrid clinical trials
by: Ratta, Marco, et al.
Published: (2025) -
Using joint models in phase I dose-finding designs in oncology: considerations for frequentist approaches
by: Chen, Xijin, et al.
Published: (2025) -
On Inclusion of Covariates in Model Based Dose Finding Clinical Trial Designs
by: Adrien Ollier, et al.
Published: (2025) -
Robust Bayesian hierarchical models for basket trials enabling joint evaluation of toxicity and efficacy
by: Cao, Zhi, et al.
Published: (2025) -
Evaluating hybrid controls methodology in early-phase oncology trials: a simulation study based on the MORPHEUS-UC trial
by: Wang, Guanbo, et al.
Published: (2022)